MRVT Miravant Med Tech: Infinity and Beyond?

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
MRVT Miravant Med Tech: Infinity and Beyond?

An SI Board Since September 1997

Posts	SubjectMarks	Bans	Symbol
67	6	0	MRVT

Emcee: rgus	Type: Unmoderated

Introduction Market Data Compact

Robertson's Don Ellis initiates coverage on Miravant Med with a "BUY." Miravant has patented technology for photo-active cancer treatment. 1998 will step-up momentum with five or so trials, including a Ph III for breast cancer, of manifold indications. To boot, their treatment has a low side-effect profile. Earnings start to dribble in '00, and gush in '01. Now, let's get beyond this funny-mental fodder to the business at hand: making money. So...rough diamond or hype job?

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
67	Cyberonics (CYBX) trial received "insufficient stimulation," not MRVT.	Marty Rubin	-	1/24/2002
66	I haven't seen the report. However, in general, Phase II trials are intende	Ian@SI	-	1/24/2002
65	Ian, Do you believe the company which said Phase III were 50% underdosed? Than	Marty Rubin	-	1/24/2002
64	Alan, Is there anything else promising for MRVT at this point? I was planning	Marty Rubin	-	1/24/2002
63	As SnET2 was the most advanced potential competitor from a Clinical Trial perspe	Ian@SI	-	1/15/2002
62	I noticed the same thing, and I pretty much put up the press release to document	Alan Gallaspy	-	1/15/2002
61	Alan, In the preceding post which was on Sept 12th, I asked, "In a slide	Ian@SI	-	1/15/2002
60	Miravant's eye treatment disappoints Stock plunges after firm says drug fail	Alan Gallaspy	-	1/14/2002
59	In a slide comparing industry participants, I saw a one-liner saying that SnET2	Ian@SI	-	9/12/2001
58	Monday June 4, 4:05 pm Eastern Time Press Release Miravant to Start Clinical Tr	betone	-	6/4/2001
57	Buying by a certain insider is the key to share price going higher. If I am wron	straight-->arrow	-	11/29/2000
56	John, You're wildly optimistic on the high side, IMO. QLTI has had FDA ap	Ian@SI	-	11/29/2000
55	straight, Good luck. Actually, in six months this stock will either be $100 or	John Lacelle	-	11/29/2000
54	Buying 1500 shares today. Like insider buys and Co. is in a perfect group for pr	straight-->arrow	-	11/29/2000
53	Wednesday July 5, 7:10 pm Eastern Time Company Press Release Miravant Presents C	Ian@SI	-	7/5/2000
52	Some meaningful news to add to the torrent of posts recently. ;-) Miravant Me	Ian@SI	-	3/27/2000
51	LESS than 30 days from the J&J news..................	Thomas J. Smith	-	9/23/1999
50	15 by wed. I think monday may be to soon for this 15 move.	Thomas J. Smith	-	9/10/1999
49	15 by Monday............. Monday morning = 15 before resistance is met.	Thomas J. Smith	-	9/9/1999
48	BUYOUT???? Not at liberty to say!	Thomas J. Smith	-	9/9/1999
47	'Haven't looked at this one in some time. It's got plenty of work	rgus	-	7/27/1999
46	all... after reading the investor packet from miravant medical technologies, i	soozathelooza	-	7/14/1999
45	Anyone left? EOM	Michael Anthony	-	7/7/1999
44	whats the rush to buy now. they will have no phase 3 data or catalyst for at le	Bioscoop	-	4/16/1999
43	Hello Tony, I am looking at June 7.5 calls or some September 10 calls. I am goi	FD JR.	-	3/24/1999

Go to reply# or date (mm/dd/yy):